Technology | October 07, 2013

AliveCor Unveils Lower Battery Consumption Smartphone Heart Monitor

Technology can be used with iOS and Android smartphones

patient monitors ecg software mobile devices alivecore heart monitor

October 7, 2013 — At the University of Southern California Body Computing Conference, AliveCor Inc. announced its new versatile Heart Monitor, a device that attaches to compatible smartphones and smartphone cases.

The new design includes the proprietary AliveCor ultrasound technology that enables a clinical-quality electrocardiogram (ECG) recording of the heart’s activity while minimizing battery drain. The compact design is transferable among various mobile devices.

The U.S. Food and Drug Administration (FDA)-cleared Heart Monitor attaches directly to the back of the mobile device or its case with the universal attachment plate. Current Android devices supported are the Samsung Galaxy S3, S4, and HTC One. Apple devices supported are the iPhone 4, 4S, 5 and the iPod touch 5. AliveCor also offers cases for the Galaxy S4 and for the iPhone 4, 4S, and 5.

For more information: www.alivecor.com


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now